SavedAdd your journal

Journals / İnönü Üniversitesi Tıp Fakültesi Dergisi / 2008 / Cilt: 15 - Sayı: 2

Relation between renal cell cancer and urinary nuclear matrix protein

Böbrek hücreli kanser ile üriner nükleer matriks proteini arasındaki ilişki

Cüneyt ÖZDEN
Ali MEMİŞ
Özdem Levent ÖZDAL
Utku ÖZEN
Binhan Kağan AKTAŞ
Sedat YAHŞİ
Pages
75–78
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Our results showed that urinary NMP22 test was not useful as a marker for patients with RCC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ABSTRACT Early diagnosis is essential to establish long term survival with curative surgical treatment in renal tumours.
📊
Key Findings & Data:Material and methods: Of the total 55 patients included in our study, 27 (RCC group) were candidate for radical nephrectomy due to solid renal mass on computerized tomography (CT) and 28 (control group) had no known solid renal mass on CT/ abdominopelvic ultrasound (USG).
💡
Conclusion & Impact:Conclusions: Our results showed that urinary NMP22 test was not useful as a marker for patients with RCC.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

ABSTRACT Early diagnosis is essential to establish long term survival with curative surgical treatment in renal tumours. Plenty of tumour markers have been evaluated for early detection but a tumour marker spesific to renal cell cancer (RCC) has not been discovered yet. Urinary NMP test results of radical nephrectomy planned patients due to renal mass were evaluated in this study. Material and methods: Of the total 55 patients included in our study, 27 (RCC group) were candidate for radical nephrectomy due to solid renal mass on computerized tomography (CT) and 28 (control group) had no known solid renal mass on CT/ abdominopelvic ultrasound (USG). Urinary NMP22 test was applied to all patients. Results: In RCC group, renal mass diameter was 7 cm in %25.9 of the patients (n=7). %3.7 of the patients (n=1) had positive urinary NMP22 test. In the control group, %3.6 of the patients (n=1) had positive urinary NMP22 test. There was not any statistically significant difference between the groups regarding to urinary NMP22 test positivity. Conclusions: Our results showed that urinary NMP22 test was not useful as a marker for patients with RCC.

Özet

ÖZET: ÖZET Giriş: Böbrek tümörlerinde küratif cerrahi tedavi ile uzun dönem sağ kalım sağlamak için erken tanı şarttır. Bu amaçla birçok tümör belirleyicisi üzerinde çalışmalar yapılmış fakat böbrek hücreli kansere (BHK) özgül bir tümör belirteci henüz tanımlanmamıştır. Bu çalışmada renal kitle nedeniyle radikal nefrektomi planlanan hastalarda üriner NMP test sonuçları değerlendirildi. Materyal-Metot:Kliniğimizde abdominopelvik bilgisayarlı tomografide (BT) solid renal kitle nedeniyle radikal nefrektomi operasyonu planlanan 27 hasta (BHK grubu) ve abdominopelvik ultrasonografi (USG) veya BT''de solid renal kitlesi olmadığı bilinen 28 hastayı (kontrol grubu) içeren toplam 55 hasta çalışmaya dahil edildi. BHK ve kontrol grubundaki tüm olgulara üriner NMP22 testi uygulandı. Bulgular:BHK grubunda hastaların %25.9'unda (n=7) renal kitle çapı 4 cm'den küçük, %48'1'de (n=13) 4-7 cm arası, %25.9'unda (n=7) 7 cm'den büyük idi. Bu grubda hastaların %3.7'sinde (n=1) üriner NMP22 testi pozitif idi. Bu oran kontrol hasta grubunda %3.6 (n=1) olarak tespit edildi. Her iki grup arasında üriner NMP22 testinin pozitif olma oranı bakımından istatistiksel olarak anlamlı fark yoktu. Sonuç Çalışmamızdan elde ettiğimiz bulgular üriner NMP22 testinin BHK'lı hastalarda bir markır olarak faydalı bir yöntem olmadığını göstermiştir. Anahtar Kelimeler: Böbrek hücreli kanser; Nükleer matriks; Tümör belirleyicileri.

🔖

Cite This Article

ÖZDEN, C., MEMİŞ, A., ÖZDAL, Ö. L., ÖZEN, U., AKTAŞ, B. K., YAHŞİ, S. (2022). Relation between renal cell cancer and urinary nuclear matrix protein. İnönü Üniversitesi Tıp Fakültesi Dergisi, Cilt: 15 - Sayı: 2, 75–78. https://ajindex.com/articles/548615

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Jacqmin D, van Poppel H, Kirkali Z, Mickisch G. Renal cancer. Eur Urol 2001; 39: 361–9
  2. Divrik T, Yıldırım Ü, Zorlu F, Dinçer H, Ergör G. Rastlantısal böbrek tümörleri erken evrede mi yakalanıyor? Türk Üroloji Dergisi 2001; 27: 424–7
  3. Ljunberg B, Grankvist K, Rasmunson T. Serum acute phase reactants and prognosis in renal cell carcinoma. Cancer 1995; 76: 1435–9
  4. Masuda H, Kurita Y, Suzuki K, Fujita K, Aso Y. Predictive value of serum immunosuppressive acidic protein for staging renal cell carcinoma: comparison with other tumour markers. Br J Urol 1997; 80: 25–9
  5. Pienta KJ, Partin AW, Coffey DS. Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res 1989; 15: 2525–32
  6. Stuurman N, Meijne AM, van der Pol AJ, de Jong L, van Driel R, van Renswoude J. The nuclear matrix from cells of different origin. Evidence for a common set of matrix proteins. J Biol Chem 1990; 5: 5460–5
  7. Yang CH, Lambie EJ, Snyder M. NuMA: an unusually long coiled-coil related protein in the mammalian nucleus. J Cell Biol 1992; 116:1303–17
  8. Keesee SK, Briggman JV, Thill G, Wu YJ. Utilisation of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gene Expr 1996; 6: 189–214
  9. Carpinito GA, Stadler WM, Briggman JV, Chodak GW, Church PA, Lamm DL, Lange PH, Messing EM, Pasciak RM, Reservitz GB, Ross RN, Rukstalis DB, Sarosdy MF, Soloway MS, Thiel RP, Vogelzang N, Hayden CL. Urinary nuclear matriks protein as a marker for TCC of the urinary tract. J Urol 1996; 156: 1280–5
  10. Huang S, Rhee E, Patel H, Park E, Kaswick J. Urinary NMP22 and renal cell carcinoma. Urology 2000; 55: 227–30
  11. Ozer G, Altinel M, Kocak B, Yazicioglu A, Gonenc F. Value of urinary NMP–22 in patients with renal cell carcinoma. Urology 2002; 60: 593–7
  12. Kaya K, Ayan S, Gokce G, Kilicarslan H, Yildiz E, Gultekin EY. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma. Scand J Urol Nephrol 2005; 39: 25–9
  13. Güler C, Tüzel C, Şamlı M, Demirbaş M. Yüzeyel Mesane Tümörlerinde Tanısal ve Prognostik Yeni Belirleyiciler, Kocatepe Tıp Dergisi 2006; 7: 1–9
  14. Çal Ç, Erdoğan Ö, Kosova B, Erken F, Veral A, Delibaş M. İdrar nmp22 testi, telomeraz testi ve sitolojisinin tek veya birlikte kullanımları yüzeyel mesane tümörü nükslerinin tanısında yeterli olabilir mi? Türk Üroloji Dergisi 2006; 32:472–7
  15. Zippe C, Pandrangi L, Agarwal A. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer. J Urol 1999; 161: 62–5